Startups
Immusoft
Develops cell therapies by programming a patient’s B cells to produce therapeutic proteins. Its Immune System Programming platform aims to turn these antibody-producing cells into a lasting source of medicines for rare genetic diseases and other conditions with unmet treatment needs.
Team
Bruce LevineScientific Advisory Board Member |
David LowenschussGeneral Counsel |
Hans-Peter KiemScientific Advisory Board Member |
Julia MooreBoard Member |
Lou ArcudiChief Financial Officer |
Matthew ScholzFounder and Board Member |
Michael C. CarrollScientific Advisory Board Member |
Peter SageScientific Advisory Board Member |
Rob HayesChief Scientific Officer |
Robert SikorskiChief Medical Officer and Scientific Advisory Board Member |
Scott McIvorChief Development Officer |
 Sean AinsworthChief Executive Officer and Board Member |
Tony SunBoard Member |